Medicare payment cuts for osteoporosis testing reduced use despite tests' benefit in reducing fractures

Health Affairs

Volumn 30, Issue 12, 2011, Pages 2362-2370

  King, Alison B ^a   Fiorentino, Donna M ^b  

^a Doxy me Research   (United States)

^b Intl Soc for Clinical Densitometry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; GOLD STANDARD; HEALTH CARE POLICY; HUMAN; MEDICARE; OSTEOPOROSIS; PROSPECTIVE PAYMENT; REIMBURSEMENT;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; FRACTURES, BONE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MEDICARE; OSTEOPOROSIS; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 84855666535     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.0233     Document Type: Article

References (32)

1. King AB, Saag KG, Burge RT, Pisu M, Goel N. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporos Int. 2005;16(12):1545-57.
2. National Osteoporosis Foundation. America's bone health: the state of osteoporosis and low bone mass in our nation. Washington (DC): The Foundation; 2002.
3. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007; 22(3):465-75.
4. O'Malley CD, Johnston SS, Lenhart G, Cherkowski G, Palmer L, Morgan SL. Trends in dual-energy xray absorptiometry in the United States, 2000-2009. J Clin Densitom. 2011;14(2):100-7.
5. Agency for Healthcare Research and Quality. National healthcare disparities report 2010. Rockville (MD): AHRQ; 2011. (Pub. No. 11-0005).
6. Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews R, et al. Longitudinal trends in use of bone mass measurement among older Americans, 1999-2005. J Bone Miner Res. 2008;23(7):1061-7.
7. Department of Health and Human Services. Bone health and osteoporosis: a report of the surgeon general. Washington (DC): HHS; 2004. p. 192.
8. Medicare Evidence Development and Coverage Advisory Committee. Transcript, MEDCAC meeting 4/20/2008: Medicare evidentiary priorities [Internet]. Baltimore (MD): Centers for Medicare and Medicaid Services; [updated 2008 May 20; cited 2011 Nov 14]. Available from: https://www.cms.gov/faca/downloads/id42c.pdf
9. Medicare Evidence Development and Coverage Advisory Committee. Score sheet, MEDCAC meeting 4/20/2008: Medicare evidentiary priorities [Internet]. Baltimore (MD): Centers for Medicare and Medicaid Services; [updated 2008 May 20; cited 2011 Nov 14]. Available from: https://www.cms.gov/faca/downloads/id42b.htm
10. Bone mass measurement: conditions for coverage and frequency standards. 42 C.F.R. Sec. 410.31.
11. US Preventive Services Task Force. Screening for osteoporosis: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2011;154(5):356-64.
12. Department of Health and Human Services. Medicare program: revisions to payment policies, five-year review of work relative value units, changes to the practice expense methodology under the physician fee schedule, and other changes to payment under Part B; revisions to the payment policies of ambulance services under the fee schedule for ambulance services; and ambulance inflation factor update for CY 2007; final rule. Fed Regist. 2006;71(231): 69623-70274.
13. Binkley N, Laster A, International Society for Clinical Densitometry, Middletown, CT. Letter to: K Weems (Centers for Medicare and Medicaid Services, Baltimore, MD). 2007 Aug 31.
14. To access the Appendix, click on the Appendix link in the box to the right of the article online
15. Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Annual reports. Washington (DC): The Boards; 2006-09, 2011. Table IVB2.
16. To order the Medicare file, see Centers for Medicare and Medicaid Services. Physician/Supplier Procedure Summary Master File [Internet]. Baltimore (MD): CMS; [cited 2011 Nov 10]. Available from: https://www.cms.gov/non identifiabledatafiles/06_ physiciansupplierproceduresummarymasterfile.asp
17. Kanis JA. FRAX WHO Fracture Risk Assessment Tool [home page on the Internet]. Sheffield (England): World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield; [cited 2011 Oct 27]. Available from: http://www.shef.ac.uk/FRAX/
18. Leslie WD, Majumdar SR, Lix LM, Johansson H, Olden A, McCloskey E, et al. High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int. 2011 Mar 2. [Epub ahead of print].
19. International Society for Clinical Densitometry, International Osteoporosis Foundation. 2010 official positions on FRAX [Internet]. Middletown (CT): ISCD; [cited 2011 Oct 27]. Available from: http://www.iscd.org/Visitors/pdfs/Official%20Positions%20ISCD-IOF%20FRAX.pdf
20. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington (DC): The Foundation; 2010.
21. Curtis JR, Laster A, Becker DJ, Carbone L, Gary LC, Kilgore ML, et al. The geographic availability and associated utilization of dual energy x-ray (DXA) testing among older persons in the US. Osteoporos Int. 2008;20:1553-61.
22. American Association of Clinical Endocrinologists, International Society for Clinical Densitometry. DXA testing undermining osteoporosis prevention. Jacksonville (FL): AACE; 2009 Mar.
23. El-Gamil A, DaVanzo JE, Dobson A. Assessing the costs of performing DXA services in the office-based setting [Internet]. Falls Church (VA): Lewin Group; 2007 Oct 31 [cited 2011 Oct 27]. Available from: https://www.aace.com/sites/default/files/DXAFinalReport.pdf
24. American Association of Clinical Endocrinologists Osteoporosis Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopaual osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003;9:561.
25. National Committee for Quality Assurance. State of healthcare quality 2010. Washington (DC): NCQA; 2010.
26. Centers for Medicare and Medicaid Services. Appendix B in: 2009 PQRI Program: details for 2009 reporting experience including trends 2007-2010 [Internet]. Baltimore (MD): CMS; [modified 2011 Apr 5; cited 2011 Nov 10]. Available from: https://www.cms.gov/PQRS/2009/itemdetail.asp?filterType=none&filterByDID=-99&sortByDID=1&sortOrder=ascending&itemID=CMS1246584&intNumPerPage=10
27. Pressman A, Forsyth B, Ettinger B, Tosteson ANA. Initiation of osteoporosis treatment after bone mineral testing. Osteoporos Int. 2001;12: 337-42.
28. Barr RJ, Stewart A, Torgerson DJ, Reid DM. Population screening for osteoporosis risk: a randomized control trial of medication use and fracture risk. Osteoporos Int. 2010;21(4):561-8.
29. Fitt NS, Mitchell SL, Cranney A, Gulenchyn K, Huang M, Tugwell P. Influence of bone densitometry results on the treatment of osteoporosis. CMAJ. 2001;164(6):777-81.
30. Kern LM, Powe NR, Levine MA, Fitzpatrick AL, Harris TB, Robbins J, et al. Association between screening for osteoporosis and the incidence of hip fracture. Ann Intern Med. 2005; 142:173-81.
31. Newman ED, Ayoub WT, Starkey RH, Diehl JM, Wood GC. Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporos Int. 2003;14(2): 146-51.
32. Dell R, Greene D, Schelkun SR, Williams K. Osteoporosis disease management: the role of the orthopaedic surgeon. J Bone Joint Surg Am. 2008;90Suppl 4:188-94.